These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 14702259)

  • 1. Association of anticholinergic load with impairment of complex attention and memory in schizophrenia.
    Minzenberg MJ; Poole JH; Benton C; Vinogradov S
    Am J Psychiatry; 2004 Jan; 161(1):116-24. PubMed ID: 14702259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates.
    Bilder RM; Goldman RS; Robinson D; Reiter G; Bell L; Bates JA; Pappadopulos E; Willson DF; Alvir JM; Woerner MG; Geisler S; Kane JM; Lieberman JA
    Am J Psychiatry; 2000 Apr; 157(4):549-59. PubMed ID: 10739413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive burden of anticholinergic medications in psychotic disorders.
    Eum S; Hill SK; Rubin LH; Carnahan RM; Reilly JL; Ivleva EI; Keedy SK; Tamminga CA; Pearlson GD; Clementz BA; Gershon ES; Keshavan MS; Keefe RSE; Sweeney JA; Bishop JR
    Schizophr Res; 2017 Dec; 190():129-135. PubMed ID: 28390849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Medication Anticholinergic Burden on Cognitive Performance in People With Schizophrenia.
    Ang MS; Abdul Rashid NA; Lam M; Rapisarda A; Kraus M; Keefe RSE; Lee J
    J Clin Psychopharmacol; 2017 Dec; 37(6):651-656. PubMed ID: 29016375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schizoaffective disorder: a form of schizophrenia or affective disorder?
    Evans JD; Heaton RK; Paulsen JS; McAdams LA; Heaton SC; Jeste DV
    J Clin Psychiatry; 1999 Dec; 60(12):874-82. PubMed ID: 10665641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic medications: linking receptor antagonism to neuropsychological functioning in first episode psychosis.
    Baitz HA; Thornton AE; Procyshyn RM; Smith GN; MacEwan GW; Kopala LC; Barr AM; Lang DJ; Honer WG
    J Int Neuropsychol Soc; 2012 Jul; 18(4):717-27. PubMed ID: 22472219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive neuropsychological functioning in New Zealand Māori diagnosed with schizophrenia.
    Kake TR; Garrett N; Te Aonui M
    Aust N Z J Psychiatry; 2016 Jun; 50(6):566-76. PubMed ID: 26494850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia.
    Vinogradov S; Fisher M; Warm H; Holland C; Kirshner MA; Pollock BG
    Am J Psychiatry; 2009 Sep; 166(9):1055-62. PubMed ID: 19570929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons.
    Hobart MP; Goldberg R; Bartko JJ; Gold JM
    Am J Psychiatry; 1999 Dec; 156(12):1951-7. PubMed ID: 10588410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression.
    Hill SK; Keshavan MS; Thase ME; Sweeney JA
    Am J Psychiatry; 2004 Jun; 161(6):996-1003. PubMed ID: 15169687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of medications with anticholinergic properties and cognitive function in a young-old community sample.
    Low LF; Anstey KJ; Sachdev P
    Int J Geriatr Psychiatry; 2009 Jun; 24(6):578-84. PubMed ID: 19021151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Executive attention deficits in schizophrenia: putative mandatory and differential cognitive pathology domains in medicated schizophrenia patients.
    Meiron O; Hermesh H; Katz N; Weizman A
    Psychiatry Res; 2013 Aug; 209(1):1-8. PubMed ID: 23102537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medications and verbal memory impairment in schizophrenia: the role of anticholinergic drugs.
    Brébion G; Bressan RA; Amador X; Malaspina D; Gorman JM
    Psychol Med; 2004 Feb; 34(2):369-74. PubMed ID: 14982143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between medication treatments and neuropsychological test performance in schizophrenia.
    Sweeney JA; Keilp JG; Haas GL; Hill J; Weiden PJ
    Psychiatry Res; 1991 Jun; 37(3):297-308. PubMed ID: 1679950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia.
    Haddad C; Salameh P; Sacre H; Clément JP; Calvet B
    BMC Psychiatry; 2023 Jan; 23(1):61. PubMed ID: 36694187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective memory in schizophrenia: the impact of varying retrospective-memory load.
    Altgassen M; Kliegel M; Rendell P; Henry JD; Zollig J
    J Clin Exp Neuropsychol; 2008 Oct; 30(7):777-88. PubMed ID: 18608664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Working memory as a predictor of negative symptoms and functional outcome in first episode psychosis.
    González-Ortega I; de Los Mozos V; Echeburúa E; Mezo M; Besga A; Ruiz de Azúa S; González-Pinto A; Gutierrez M; Zorrilla I; González-Pinto A
    Psychiatry Res; 2013 Mar; 206(1):8-16. PubMed ID: 22985548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticholinergic Burden and Cognition in Older Patients With Schizophrenia.
    Tsoutsoulas C; Mulsant BH; Kumar S; Ghazala Z; Voineskos AN; Menon M; Pollock BG; Rajji TK
    J Clin Psychiatry; 2017; 78(9):e1284-e1290. PubMed ID: 29188908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliable change indexes for memory performance in schizophrenia as a means to determine drug-induced cognitive decline.
    Moritz S; Iverson GL; Woodward TS
    Appl Neuropsychol; 2003; 10(2):115-20. PubMed ID: 12788686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.